Outpatient diuretic intensification, NT-proBNP and eGFR as early markers of disease progression in patients with ATTR-CM: a validation study

Back

ESC2025 Premium Access

Outpatient diuretic intensification, NT-proBNP and eGFR as early markers of disease progression in patients with ATTR-CM: a validation study

Session: Cardiac amyloidosis: light chain to transthyretin

Topic: Infiltrative Myocardial Disease

Speaker: Doctor A. Sheikh (London, GB)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Awais Sheikh

National Amyloidosis Centre, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

Sex differences in cardiac amyloidosis: a clustering-based analysis

Speaker: Assistant Professor A. Zaroui (Creteil, FR)

Red blood cell distribution width and red blood cell distribution width/albumin ratio as predictors of mortality in light chain cardiac amyloidosis

Speaker: Doctor X. Li (Beijing, CN)

Subtle elevations in carcinoembryonic antigen are associated with increased all-cause mortality in patients with light chain cardiac amyloidosis

Speaker: Doctor X. Li (Beijing, CN)

Prognostic significance of ventricular tachycardia characteristics in patients with light-chain cardiac amyloidosis

Speaker: Doctor J. Wang (Beijing, CN)

Synthetic extracellular volume from myocardial radiomics to identify transthyretin cardiac amyloidosis from routinely acquired CT angiography scans

Speaker: Assistant Professor A. Antonopoulos (Athens, GR)

Access the full session

Cardiac amyloidosis: light chain to transthyretin

Speakers: Doctor A. Sheikh, Assistant Professor A. Zaroui, Doctor X. Li, Doctor X. Li, Doctor J. Wang...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources